PTPRZ1-METFUSION GENe (ZM-FUGEN) :,,II/III

Zhaoshi Bao1,2, Shouwei Li2,3, Liang Wang2,4

  • 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.

PubMed
概括

这项研究评估了vebreltinib用于带有PTPRZ1-MET融合的质瘤患者. 该试验评估了安全性和疗效,可能扩大针对性治疗更多的质瘤病例.